Glycogen
Research stageRecent clinical, regulatory, research and industry developments relating to this drug.
Neurological glycogen storage diseases and emerging therapeutics.
The multifaceted roles of the brain glycogen.
Mechanism of free fatty acid-induced insulin resistance in humans.
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes5
Journals, researchers & institutions
- The Journal of clinical investigation2
- Journal of neurochemistry1
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics1
- Byrne BJ2
- Corti M2
- Gentry MS2
- Sun RC2
- Vander Kooi CW2
- Boden G1
- Chen X1
- Cline GW1
- College of Medicine2
- Powell Gene Therapy Center2
- Adult Polyglucosan Body Disease Research Foundation1
- Center for Advanced Spatial Biomolecule Research1
- Department of Physical Therapy and Breathing Research and Therapeutics Center1
- Temple University School of Medicine1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature